Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C
International Journal of Molecular Sciences · 05.04.2023 · 24 (7) · 6783
DOI: 10.3390/ijms24076783 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.04.2023. Verfasst von Maxim Sinitsky und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Medicine, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atherosclerosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
HMG-CoA reductase inhibitors (statins) are widely used in the therapy of atherosclerosis and have a number of pleiotropic effects, including DNA repair regulation. We studied the cytogenetic damage and the expression of DNA repair genes (DDB1, ERCC4, and ERCC5) in human coronary artery (HCAEC) and internal thoracic artery endothelial cells (HITAEC) in vitro exposed to mitomycin C (MMC) (positive control), MMC and atorvastatin (MMC+Atv), MMC followed by atorvastatin treatment (MMC/Atv) and 0.9% NaCl (negative control). MMC/Atv treated HCAEC were characterized by significantly decreased micronuclei (MN) frequency compared to the MMC+Atv group and increased nucleoplasmic bridges (NPBs) frequency compared to both MMC+Atv treated cells and positive control; DDB1, ERCC4, and ERCC5 genes were upregulated in MMC+Atv and MMC/Atv treated HCAEC in comparison with the positive control. MMC+Atv treated HITAEC were characterized by reduced MN frequency compared to positive control and decreased NPBs frequency in comparison with both the positive control and MMC/Atv group. Nuclear buds (NBUDs) frequency was significantly lower in MMC/Atv treated cells than in the positive control. The DDB1 gene was downregulated in the MMC+Atv group compared to the positive control, and the ERCC5 gene was upregulated in MMC/Atv group compared to both the positive control and MMC+Atv group. We propose that atorvastatin can modulate the DNA damage repair response in primary human endothelial cells exposed to MMC in a cell line- and incubation scheme-dependent manner that can be extremely important for understanding the fundamental aspects of pleoitropic action of atorvastatin and can also be used to correct the therapy of patients with atherosclerosis characterized by a high genotoxic load.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genome Medicine, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia.
- Laboratory for Molecular, Translation and Digital Medicine, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia.
- Department of Genetic and Fundamental Medicine, Kemerovo State University, Kemerovo 650000, Russia.
ORCID-Profile: Maxim Sinitsky, Anna Sinitskaya, Daria Shishkova, Varvara Minina, Anastasia Ponasenko
Förderung
- Russian Science Foundation
Zitieren
APA
Sinitsky, M., Asanov, M., Sinitskaya, A., Shishkova, D., Khutornaya, M., Minina, V., & Ponasenko, A. (2023). Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C. International Journal of Molecular Sciences, 24(7), 6783. https://doi.org/10.3390/ijms24076783
Vancouver
Sinitsky M, Asanov M, Sinitskaya A, Shishkova D, Khutornaya M, Minina V, et al. Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C. International Journal of Molecular Sciences. 2023;24(7):6783. doi:10.3390/ijms24076783
BibTeX
@article{Sinitsky2023,
author = {Sinitsky, Maxim and Asanov, Maxim and Sinitskaya, Anna and Shishkova, Daria and Khutornaya, Maria and Minina, Varvara and Ponasenko, Anastasia},
title = {Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6783},
doi = {10.3390/ijms24076783}
}
EUVIMED